Secukinumab

Overview

Categories

No Categories Defined

Primary Characterstics

Indications

Back to top

Pharmacokinetics

Back to top

Contraindications

Back to top

Drug Interactions

Back to top

Side Effects

Back to top

Dosage

Secukinumab's dosage details are as follows:
Dose Single Dose Frequency Route Instructions

Adult Dosage

150 mg150 (150)As recommended.subcutaneousFor Psoriatic Arthritis and Ankylosing Spondylitis : At weeks 0, 1, 2, 3, and 4 and every 4 weeks thereafter. Without a loading dosage is 150 mg every 4 weeks
300 mg300 (300)As recommended.subcutaneousFor Plaque Psoriasis : injection at Weeks 0, 1, 2, 3, and 4 followed by 300 mg every 4 weeks. For some patients, a dose of 150 mg may be acceptable.

Paedriatic Dosage (20kg)

No data regarding the Paedriatic dosage details of Secukinumab is available.

Neonatal Dosage (3kg)

No data regarding the neonatal dosage details of Secukinumab is available.

High Risk Groups

Back to top

Warning / Precautions

Back to top

Storage Conditions

Back to top

Interference in Pathology

Back to top

Brands / Trade Names of Secukinumab

Back to top

Manufacturers of Secukinumab in Pakistan

Back to top

Previous Drug Generic - Next Drug Generic


Suggested Pages